| Product NDC: | 60432-616 |
| Proprietary Name: | Lithium Hydroxide Monohydrate |
| Non Proprietary Name: | Lithium Hydroxide Monohydrate |
| Active Ingredient(s): | 8 meq/5mL & nbsp; Lithium Hydroxide Monohydrate |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 60432-616 |
| Labeler Name: | Morton Grove Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA070755 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 19860521 |
| Package NDC: | 60432-616-16 |
| Package Description: | 473 mL in 1 BOTTLE (60432-616-16) |
| NDC Code | 60432-616-16 |
| Proprietary Name | Lithium Hydroxide Monohydrate |
| Package Description | 473 mL in 1 BOTTLE (60432-616-16) |
| Product NDC | 60432-616 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Lithium Hydroxide Monohydrate |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 19860521 |
| Marketing Category Name | ANDA |
| Labeler Name | Morton Grove Pharmaceuticals, Inc. |
| Substance Name | LITHIUM HYDROXIDE MONOHYDRATE |
| Strength Number | 8 |
| Strength Unit | meq/5mL |
| Pharmaceutical Classes | Mood Stabilizer [EPC] |